NCT01461018 - Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Primary Immune Deficiency

Interventions

BIOLOGICAL

Immune globulin subcutaneous (Human)

IgPro20 is a 20% (weight per volume \[w/v\]) liquid formulation of human immunoglobulin for subcutaneous (SC) use.

Trial Locations (9)

Study site, Nagoya

Study site, Chiba

Study site, Fukuoka

Study site, Gifu

Study Site, Sapporo

Study site, Moriguchi

Study site, Koshigaya

Study site, Tokorozawa

Study site, Bunkyō City